Shares of Ranbaxy Laboratories Ltd and Strides Arcolab Ltd dropped in Mumbai trading after the US raised manufacturing concerns following factory inspections.
The US Food and Drug Administration (FDA) issued an import alert against Ranbaxy’s plant in Mohali in India’s Punjab state, according to a notice dated on Friday.
Shares of Ranbaxy, the country’s largest drugmaker, dropped as much as 35 percent to 297.25 rupees, headed for the biggest loss since the shares started trading in January 1991.
“Some of the products they have filed from this unit will get postponed,” Rohit Bhat, a health-care analyst at B&K Securities India Pvt Ltd, said in a telephone interview. “The resolution of this unit might take another couple of years.”
Strides Arcolab Ltd said a facility in Bangalore received a warning letter after an inspection found reasons for concern. An import alert was placed on a Wockhardt Ltd factory in India in May. The checks may be a sign that the FDA is being more vigilant of overseas suppliers. The regulator inspects foreign drug facilities once every nine years on average, compared with once every 30 months for US plants, the US Government Accountability Office reported in September 2010.
Ranbaxy’s shares traded at 334.2 rupees, down by 27 percent, as of 11:42am and has lost a third of its value this year.
Strides’s shares fell as much as 6.8 percent to 839 rupees, headed for the biggest decline since Aug. 14.
Products from companies on the FDA’s import alert list may be subject to detention without physical examination.
Ranbaxy agreed in May to pay US$500 million to resolve fraud allegations made in a whistle-blower’s lawsuit and federal criminal charges that it sold batches of drugs that were improperly manufactured, stored and tested.
It also admitted to lying to the FDA about how it tested drugs at two of its Indian plants.
“It doesn’t seem that things have changed,” Bhat said. “Everyone knows that the company has been facing FDA compliance issues for their other units, but it was expected that they would have learned from earlier experiences and hoped that they would be able to clear the FDA for this unit.”
Strides responded to the FDA’s observations made during an inspection of a sterile manufacturing facility in Bangalore in June by implementing corrective actions, it said in a statement yesterday.
“The company is committed to work collaboratively and expeditiously with the US FDA to resolve concerns cited in the warning letter in the shortest possible time,” Strides said.
The Eurovision Song Contest has seen a surge in punter interest at the bookmakers, becoming a major betting event, experts said ahead of last night’s giant glamfest in Basel. “Eurovision has quietly become one of the biggest betting events of the year,” said Tomi Huttunen, senior manager of the Online Computer Finland (OCS) betting and casino platform. Betting sites have long been used to gauge which way voters might be leaning ahead of the world’s biggest televised live music event. However, bookmakers highlight a huge increase in engagement in recent years — and this year in particular. “We’ve already passed 2023’s total activity and
Nvidia Corp CEO Jensen Huang (黃仁勳) today announced that his company has selected "Beitou Shilin" in Taipei for its new Taiwan office, called Nvidia Constellation, putting an end to months of speculation. Industry sources have said that the tech giant has been eyeing the Beitou Shilin Science Park as the site of its new overseas headquarters, and speculated that the new headquarters would be built on two plots of land designated as "T17" and "T18," which span 3.89 hectares in the park. "I think it's time for us to reveal one of the largest products we've ever built," Huang said near the
China yesterday announced anti-dumping duties as high as 74.9 percent on imports of polyoxymethylene (POM) copolymers, a type of engineering plastic, from Taiwan, the US, the EU and Japan. The Chinese Ministry of Commerce’s findings conclude a probe launched in May last year, shortly after the US sharply increased tariffs on Chinese electric vehicles, computer chips and other imports. POM copolymers can partially replace metals such as copper and zinc, and have various applications, including in auto parts, electronics and medical equipment, the Chinese ministry has said. In January, it said initial investigations had determined that dumping was taking place, and implemented preliminary
Intel Corp yesterday reinforced its determination to strengthen its partnerships with Taiwan’s ecosystem partners including original-electronic-manufacturing (OEM) companies such as Hon Hai Precision Industry Co (鴻海精密) and chipmaker United Microelectronics Corp (UMC, 聯電). “Tonight marks a new beginning. We renew our new partnership with Taiwan ecosystem,” Intel new chief executive officer Tan Lip-bu (陳立武) said at a dinner with representatives from the company’s local partners, celebrating the 40th anniversary of the US chip giant’s presence in Taiwan. Tan took the reins at Intel six weeks ago aiming to reform the chipmaker and revive its past glory. This is the first time Tan